Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors
Clinical trial NCT06132503 · RECRUITING
Trial details
- NCT number
- NCT06132503
- Sponsor
- Lantern Pharma Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-03
- Primary completion
- 2028-11-30
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.